Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties-Reference-Cited by-同舟云学术

Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties

Published:2014-08-06 Issue:1 Volume:351 Page:190-199
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Hegde Sharath S.,Hughes Adam D.,Chen Yan,Steinfeld Tod,Jasper Jeffrey R.,Lee Tae-Weon,McNamara Alexander,Martin William J.,Pulido-Rios M. Teresa,Mammen Mathai

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference25 articles.

1. L-arginine availability determines the duration of acetylcholine-induced systemic vasodilatation in vivo

2. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

3. Muscarinic receptor subtypes in airways

4. Pharmacology of Airway Smooth Muscle

5. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Phenethylamines in Medicinal Chemistry: A Review;Molecules;2023-01-14

2. Research Advances in COPD Drugs and Novel Targets;Nano LIFE;2021-09

3. Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD);Bioorganic & Medicinal Chemistry Letters;2021-06

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

;Journal of Experimental Pharmacology;2020-12

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease

;Journal of Experimental Pharmacology;2020-12